Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Withdrawal from chronic nicotine exposure alters dopamine signaling dynamics in the nucleus accumbens.

Zhang L, Dong Y, Doyon WM, Dani JA.

Biol Psychiatry. 2012 Feb 1;71(3):184-91. doi: 10.1016/j.biopsych.2011.07.024. Epub 2011 Aug 27.

2.

Alpha6-containing nicotinic acetylcholine receptors dominate the nicotine control of dopamine neurotransmission in nucleus accumbens.

Exley R, Clements MA, Hartung H, McIntosh JM, Cragg SJ.

Neuropsychopharmacology. 2008 Aug;33(9):2158-66. Epub 2007 Nov 21.

3.

Neuroadaptive changes in the mesoaccumbens dopamine system after chronic nicotine self-administration: a microdialysis study.

Rahman S, Zhang J, Engleman EA, Corrigall WA.

Neuroscience. 2004;129(2):415-24.

PMID:
15501598
4.

Mecamylamine decreases accumbal dopamine output in mice treated chronically with nicotine.

Gäddnäs H, Piepponen TP, Ahtee L.

Neurosci Lett. 2002 Sep 27;330(3):219-22.

PMID:
12270632
5.
6.

Dopamine signaling differences in the nucleus accumbens and dorsal striatum exploited by nicotine.

Zhang T, Zhang L, Liang Y, Siapas AG, Zhou FM, Dani JA.

J Neurosci. 2009 Apr 1;29(13):4035-43. doi: 10.1523/JNEUROSCI.0261-09.2009.

7.
8.

Mesolimbic dopamine and habenulo-interpeduncular pathways in nicotine withdrawal.

Dani JA, De Biasi M.

Cold Spring Harb Perspect Med. 2013 Jun 1;3(6). pii: a012138. doi: 10.1101/cshperspect.a012138.

9.
10.

Enhanced dopamine transporter function in striatum during nicotine withdrawal.

Hadjiconstantinou M, Duchemin AM, Zhang H, Neff NH.

Synapse. 2011 Feb;65(2):91-8. doi: 10.1002/syn.20820.

PMID:
20506223
11.
12.
13.

Long-term nicotine treatment down-regulates α6β2* nicotinic receptor expression and function in nucleus accumbens.

Perez XA, McIntosh JM, Quik M.

J Neurochem. 2013 Dec;127(6):762-71. doi: 10.1111/jnc.12442. Epub 2013 Oct 13.

14.
15.

Phasic D1 and tonic D2 dopamine receptor signaling double dissociate the motivational effects of acute nicotine and chronic nicotine withdrawal.

Grieder TE, George O, Tan H, George SR, Le Foll B, Laviolette SR, van der Kooy D.

Proc Natl Acad Sci U S A. 2012 Feb 21;109(8):3101-6. doi: 10.1073/pnas.1114422109. Epub 2012 Jan 20.

16.

NMDA-mediated modulation of dopamine release is modified in rat prefrontal cortex and nucleus accumbens after chronic nicotine treatment.

Grilli M, Pittaluga A, Merlo-Pich E, Marchi M.

J Neurochem. 2009 Jan;108(2):408-16. doi: 10.1111/j.1471-4159.2008.05792.x. Epub 2008 Nov 19.

17.

Contributory role for nornicotine in nicotine neuropharmacology: nornicotine-evoked [3H]dopamine overflow from rat nucleus accumbens slices.

Green TA, Crooks PA, Bardo MT, Dwoskin LP.

Biochem Pharmacol. 2001 Dec 15;62(12):1597-603.

PMID:
11755112
18.

Alpha7-nicotinic receptors modulate nicotine-induced reinforcement and extracellular dopamine outflow in the mesolimbic system in mice.

Besson M, David V, Baudonnat M, Cazala P, Guilloux JP, Reperant C, Cloez-Tayarani I, Changeux JP, Gardier AM, Granon S.

Psychopharmacology (Berl). 2012 Mar;220(1):1-14. doi: 10.1007/s00213-011-2422-1. Epub 2011 Sep 8.

PMID:
21901321
19.

Region-specific effects of N,N'-dodecane-1,12-diyl-bis-3-picolinium dibromide on nicotine-induced increase in extracellular dopamine in vivo.

Rahman S, Zhang Z, Papke RL, Crooks PA, Dwoskin LP, Bardo MT.

Br J Pharmacol. 2008 Feb;153(4):792-804. Epub 2007 Dec 3.

20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk